ALLIANCEBERNSTEIN L.P. - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 157 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$1,063,216
-25.1%
163,0700.0%0.00%
-100.0%
Q1 2024$1,420,340
-25.6%
163,070
-2.3%
0.00%0.0%
Q4 2023$1,909,691
+23.1%
166,931
+3.7%
0.00%0.0%
Q3 2023$1,550,729
-9.5%
161,0310.0%0.00%0.0%
Q2 2023$1,713,370
+1.1%
161,0310.0%0.00%0.0%
Q1 2023$1,694,046
-32.4%
161,031
-20.4%
0.00%0.0%
Q4 2022$2,505,593
+19.7%
202,227
+0.1%
0.00%0.0%
Q3 2022$2,094,000
-20.4%
202,088
-11.5%
0.00%0.0%
Q2 2022$2,632,000
-10.3%
228,300
-2.1%
0.00%0.0%
Q1 2022$2,934,000
+4.2%
233,221
-3.4%
0.00%0.0%
Q4 2021$2,816,000
-28.1%
241,521
-19.4%
0.00%
-50.0%
Q3 2021$3,916,000
+24.0%
299,825
+22.2%
0.00%
+100.0%
Q2 2021$3,157,000
+25.4%
245,321
+8.9%
0.00%0.0%
Q1 2021$2,518,000
-28.1%
225,221
-26.8%
0.00%
-50.0%
Q4 2020$3,503,000
+47.4%
307,531
+16.4%
0.00%
+100.0%
Q3 2020$2,376,000
-14.7%
264,121
-2.2%
0.00%
-50.0%
Q2 2020$2,787,000
+13.3%
270,021
+10.8%
0.00%0.0%
Q1 2020$2,460,000
-22.7%
243,760
+2.0%
0.00%0.0%
Q4 2019$3,181,000
+55.1%
238,9600.0%0.00%
+100.0%
Q3 2019$2,051,000
-21.5%
238,9600.0%0.00%
-50.0%
Q2 2019$2,614,000
-4.6%
238,960
+18.0%
0.00%0.0%
Q1 2019$2,741,000
+30.6%
202,5600.0%0.00%0.0%
Q4 2018$2,099,000
-43.9%
202,5600.0%0.00%0.0%
Q3 2018$3,739,000
-3.5%
202,5600.0%0.00%
-33.3%
Q2 2018$3,873,000
+23.9%
202,5600.0%0.00%
+50.0%
Q1 2018$3,126,000
+3.0%
202,5600.0%0.00%0.0%
Q4 2017$3,036,000
-6.4%
202,560
-1.5%
0.00%0.0%
Q3 2017$3,243,000
-25.5%
205,660
-10.8%
0.00%
-33.3%
Q2 2017$4,355,000
-19.9%
230,660
-27.7%
0.00%
-25.0%
Q1 2017$5,439,000
-12.6%
318,840
-21.6%
0.00%
-20.0%
Q4 2016$6,220,000
+75.1%
406,770
+81.9%
0.01%
+66.7%
Q3 2016$3,552,000
+21.5%
223,6600.0%0.00%0.0%
Q2 2016$2,924,000
+28.4%
223,660
+7.4%
0.00%
+50.0%
Q1 2016$2,277,000
-5.6%
208,1600.0%0.00%0.0%
Q4 2015$2,413,000
+11.2%
208,1600.0%0.00%0.0%
Q3 2015$2,169,000
-13.7%
208,160
-0.1%
0.00%0.0%
Q2 2015$2,513,000
-24.6%
208,4000.0%0.00%
-33.3%
Q1 2015$3,334,000
+4.4%
208,4000.0%0.00%0.0%
Q4 2014$3,193,000
+18.3%
208,4000.0%0.00%
+50.0%
Q3 2014$2,700,000
-15.5%
208,4000.0%0.00%
-33.3%
Q2 2014$3,195,000
+33.4%
208,400
+7.2%
0.00%
+50.0%
Q1 2014$2,395,000
+22.2%
194,402
+15.2%
0.00%0.0%
Q4 2013$1,960,000
-7.1%
168,800
-5.2%
0.00%0.0%
Q3 2013$2,110,000
+19.8%
178,027
+0.6%
0.00%0.0%
Q2 2013$1,761,000177,0000.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$169,800,00019.19%
Ally Bridge Group (NY) LLC 742,570$7,693,0005.08%
13D Management LLC 600,431$6,220,0003.26%
BRIDGER MANAGEMENT, LLC 916,314$9,493,0002.87%
Brown Capital Management 8,637,118$89,481,0001.26%
Price Jennifer C. 520,000$5,387,0001.11%
ALPHASIMPLEX GROUP, LLC 10,510$109,0001.10%
Quantedge Capital Pte Ltd 303,000$3,139,0000.97%
Monarch Partners Asset Management LLC 303,550$3,145,0000.94%
Intrinsic Value Partners, LLC 53,805$557,0000.77%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders